Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease
worldwide, and scientific studies consistently report that NAFLD development can be …

CYP2E1 is one of the fifty-seven cytochrome P450 genes in the human genome and is
highly conserved. CYP2E1 is a unique P450 enzyme because its heme iron is constitutively …

Background and aim Flavonoids are natural products of plant origin and have been shown
to be beneficial for nonalcoholic fatty liver disease (NAFLD) in animal studies. However …

Ethnopharmacological relevance Plants are a natural treasure trove; their secondary
metabolites participate in several pharmacological processes, making them a crucial …

Metabolic syndrome (MetS) is a chronic disease, including abdominal obesity, dyslipidemia,
hyperglycemia, and hypertension. It should be noted that the occurrence of MetS is closely …

Oxidative stress is among the major triggers for many important human functional disorders,
which often lead to various metabolic or tissue diseases. The aim of the study is to obtain …

Nonalcoholic fatty liver disease (NAFLD) begins with excessive triglyceride accumulation in
the liver, and overly severe hepatic steatosis progresses to nonalcoholic steatohepatitis …

Non-alcoholic fatty liver disease (NAFLD) has a global prevalence of approximately 25%
and is associated with high morbidity and high mortality. NAFLD is a leading cause of …

Recent studies suggest that treatment with SGLT-2 inhibitors can reduce hepatic lipid
storage and ameliorate non-alcoholic fatty liver disease (NAFLD) development beyond their …

Low-alcohol beverages damage the liver, whereas dealcoholized apple juice sequentially
fermented by Saccharomyces cerevisiae and Lactobacillus plantarum is a promising dietary …